The mouse alpha-myosin heavy chain promoter drives the expression of the mouse cardiac troponin I containing an arginine to histidine change in the C-terminus at residue 193 (R193H), which corresponds to the R192H point mutation linked to restrictive cardiomyopathy in humans.